1. García-Manero G, Schuster SJ, Patrick H, Martinez J. Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases. Am J Hematol. 1999; 60:130–135.
2. Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A. Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest. 2001; 120:801–808.
3. Georgiades CS, Neyman EG, Francis IR, Sneider MB, Fishman EK. Typical and atypical presentations of extramedullary hemopoiesis. AJR Am J Roentgenol. 2002; 179:1239–1243.
4. Trow TK, Argento AC, Rubinowitz AN, Decker R. A 71-year-old woman with myelofibrosis, hypoxemia, and pulmonary hypertension. Chest. 2010; 138:1506–1510.
5. Schwarz C, Bittner R, Kirsch A, Loddenkemper C, Mairinger T, Schonfeld N, et al. A 62-year-old woman with bilateral pleural effusions and pulmonary infiltrates caused by extramedullary hematopoiesis. Respiration. 2009; 78:110–113.
6. Rumi E, Passamonti F, Boveri E, De Amici M, Astori C, Braschi M, et al. Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia. Am J Hematol. 2006; 81:124–127.
7. Bajwa AA, Usman F, Wolfson D, Laos LF, Cury JD. A 62-year-old woman with dyspnea, leukocytosis, and diffuse ground-glass opacities. Chest. 2010; 137:1470–1473.
8. Jacobson AF, Marks MA, Kaplan WD. Increased lung uptake on technetium-99m-sulfur colloid liver-spleen scans in patients with hepatic venoocclusive disease following bone marrow transplantation. J Nucl Med. 1990; 31:372–374.